BD Board Increases Dividend

FRANKLIN LAKES, N.J., Nov. 20, 2017 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.75 cents per common share, an increase of 2.7 percent from the previous quarter.  The dividend will be payable on December 29, 2017 to holders of record on December 8, 2017.  The indicated annual dividend rate for fiscal year 2018 is $3.00 per share.

"We are very pleased with our strong fiscal 2017 results, which demonstrate our ability to overcome multiple headwinds and deliver on our commitments.  We enter fiscal 2018 with continued momentum in our core and look forward to the successful closing of the C.R. Bard acquisition.  We believe there are significant opportunities ahead for BD as we continue to deliver innovative healthcare solutions to our customers and their patients around the world," said Vincent A. Forlenza, Chairman and CEO.  "This is the forty-sixth consecutive fiscal year in which we have raised our dividend.  This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to our shareholders."

About BD 
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit

Kristen Cardillo, Corporate Communications – 201-847-5657
Monique Dolecki, Investor Relations – 201-847-5378

View original content:

SOURCE BD (Becton, Dickinson and Company)